Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U11 small nuclear 2, pseudogene (RNU11-2P)
- Target
- RNU11-2P
- Molecular classification
- Other: Pseudogene (specifically, a small nuclear RNA pseudogene), Not a member of families like GPCR, Ion channel, Enzyme, Transporter, Receptor, Transcription factor, or Histone modification
01
Overview
RNU11-2P refers to the RNA, U11 small nuclear 2, pseudogene—a nonfunctional gene copy related to the small nuclear RNA U11. U11 snRNA is a bona fide component of the minor spliceosomal complex, involved in pre-mRNA splicing in eukaryotes[1][3][6]. However, RNU11-2P does not produce active snRNA, as it is classified as a pseudogene; this means it is a genetic remnant with sequence similarity to U11 but is nonfunctional and not involved in biological pathways, nor is it a receptor, enzyme, or target for therapeutic agents[4][5]. If seeking a functional target, refer to "RNA, U11 small nuclear" (RNU11), not the pseudogene RNU11-2P[3][6].
- Other names
- RNA, U11 small nuclear 2, pseudogeneRNU11-2P
02
Mechanism of action
None applicable (no drugs target RNU11-2P)
03
Biological functions
None (as a pseudogene, RNU11-2P lacks or has lost biological function)
04
Disease associations
None. No established links to disease for the pseudogene RNU11-2P. Functional copies of U11 or its snRNP may be implicated in biology, but the pseudogene itself is not
05
Safety considerations
None (not a therapeutic target; no safety issues noted)
06
Interacting drugs
None (No evidence of drug interaction with RNU11-2P)
07
Biomarkers
None (no biomarkers relevant to RNU11-2P)
Beyond the preview
Go deeper on RNA, U11 small nuclear 2, pseudogene (RNU11-2P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U11 small nuclear 2, pseudogene (RNU11-2P).